These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27476631)

  • 41. Cyclophosphamide could be a better choice than methotrexate as induction treatment for patients with more severe Takayasu's arteritis.
    Sun Y; Ma L; Ma L; Kong X; Chen H; Lv P; Lin J; Liu H; Yan Y; Ji Z; Yang C; Dai S; Wan W; Zou Y; Jin X; Jiang L
    Rheumatol Int; 2017 Dec; 37(12):2019-2026. PubMed ID: 29030659
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti TNF-α in refractory Takayasu's arteritis: cases series and review of the literature.
    Comarmond C; Plaisier E; Dahan K; Mirault T; Emmerich J; Amoura Z; Cacoub P; Saadoun D
    Autoimmun Rev; 2012 Jul; 11(9):678-84. PubMed ID: 22155781
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of childhood-onset Takayasu arteritis: switching between anti-TNF and anti-IL-6 agents.
    Sener S; Basaran O; Kaya Akca U; Atalay E; Kasap Cuceoglu M; Balik Z; Aliyev E; Bayindir Y; Batu ED; Hazirolan T; Bilginer Y; Ozen S
    Rheumatology (Oxford); 2022 Nov; 61(12):4885-4891. PubMed ID: 35262635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of immunosuppressive and biological agents on refractory Takayasu arteritis patients unresponsive to glucocorticoid treatment.
    Ohigashi H; Tamura N; Ebana Y; Harigai M; Maejima Y; Ashikaga T; Isobe M
    J Cardiol; 2017 May; 69(5):774-778. PubMed ID: 27567177
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study.
    Nakaoka Y; Isobe M; Tanaka Y; Ishii T; Ooka S; Niiro H; Tamura N; Banno S; Yoshifuji H; Sakata Y; Kawakami A; Atsumi T; Furuta S; Kohsaka H; Suzuki K; Hara R; Maejima Y; Tsukamoto H; Takasaki Y; Yamashita K; Okada N; Yamakido S; Takei S; Yokota S; Nishimoto N
    Rheumatology (Oxford); 2020 Sep; 59(9):2427-2434. PubMed ID: 31951279
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up.
    Molloy ES; Langford CA; Clark TM; Gota CE; Hoffman GS
    Ann Rheum Dis; 2008 Nov; 67(11):1567-9. PubMed ID: 18677012
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tocilizumab treatment in childhood Takayasu arteritis: Case series of four patients and systematic review of the literature.
    Batu ED; Sönmez HE; Hazırolan T; Özaltın F; Bilginer Y; Özen S
    Semin Arthritis Rheum; 2017 Feb; 46(4):529-535. PubMed ID: 27515155
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serial analysis of clinical and imaging indices reveals prolonged efficacy of TNF-α and IL-6 receptor targeted therapies in refractory Takayasu arteritis.
    Youngstein T; Peters JE; Hamdulay SS; Mewar D; Price-Forbes A; Lloyd M; Jeffery R; Kinderlerer AR; Mason JC
    Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S11-8. PubMed ID: 24093733
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New treatment strategies in large-vessel vasculitis.
    Unizony S; Stone JH; Stone JR
    Curr Opin Rheumatol; 2013 Jan; 25(1):3-9. PubMed ID: 23114585
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tocilizumab and refractory Takayasu disease: Four case reports and systematic review.
    Decker P; Olivier P; Risse J; Zuily S; Wahl D
    Autoimmun Rev; 2018 Apr; 17(4):353-360. PubMed ID: 29427826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Study of serial serum myeloid-related protein 8/14 as a sensitive biomarker in Takayasu arteritis: a single centre study.
    Goel R; Nair A; Kabeerdoss J; Mohan H; Jeyaseelan V; Joseph G; Danda D
    Rheumatol Int; 2018 Apr; 38(4):623-630. PubMed ID: 29196802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The efficacy of mycophenolate mofetil in treating Takayasu arteritis: a systematic review and meta-analysis.
    Dai D; Wang Y; Jin H; Mao Y; Sun H
    Rheumatol Int; 2017 Jul; 37(7):1083-1088. PubMed ID: 28364217
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction treatment of proliferative lupus nephritis with leflunomide combined with prednisone: a prospective multi-centre observational study.
    Wang HY; Cui TG; Hou FF; Ni ZH; Chen XM; Lu FM; Xu FF; Yu XQ; Zhang FS; Zhao XZ; Zhao MH; Wang GB; Qian JQ; Cai GY; Zhu TY; Wang YH; Jiang ZP; Li YN; Mei CL; Zou WZ;
    Lupus; 2008 Jul; 17(7):638-44. PubMed ID: 18625636
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pediatric-onset Takayasu's arteritis: clinical features and short-term outcome.
    Misra DP; Aggarwal A; Lawrence A; Agarwal V; Misra R
    Rheumatol Int; 2015 Oct; 35(10):1701-6. PubMed ID: 25903354
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Takayasu arteritis: an update.
    Keser G; Aksu K; Direskeneli H
    Turk J Med Sci; 2018 Aug; 48(4):681-697. PubMed ID: 30114347
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: a five-year followup study.
    Kalden JR; Schattenkirchner M; Sörensen H; Emery P; Deighton C; Rozman B; Breedveld F
    Arthritis Rheum; 2003 Jun; 48(6):1513-20. PubMed ID: 12794818
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effectiveness of combination tocilizumab and glucocorticoids as an induction therapy in patients with Takayasu arteritis: An observational study.
    Yoshida S; Suzuki E; Matsumoto H; Yokose K; Fujita Y; Temmoku J; Matsuoka N; Yashiro-Furuya M; Asano T; Sato S; Watanabe H; Migita K
    Mod Rheumatol; 2023 Mar; 33(2):360-366. PubMed ID: 35438750
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tuberculosis and Takayasu arteritis: case-based review.
    Jansson MK; Geerdes-Fenge HF; Kangowski A; Kneitz C; Reisinger EC
    Rheumatol Int; 2019 Feb; 39(2):345-351. PubMed ID: 30607506
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Advances in the medical and surgical treatment of Takayasu arteritis.
    Liang P; Hoffman GS
    Curr Opin Rheumatol; 2005 Jan; 17(1):16-24. PubMed ID: 15604900
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term outcomes of coronary artery bypass grafting versus percutaneous coronary intervention for Takayasu arteritis patients with coronary artery involvement.
    Wang X; Dang A; Lv N; Cheng N; Cheng X; Yang Y; Song Y
    Semin Arthritis Rheum; 2017 Oct; 47(2):247-252. PubMed ID: 28457530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.